Rachel Bhatt

Rachel Bhatt is an expert in T cell receptor repertoire analysis and its application to cancer immunotherapy. Her research has identified TCR clonotypes associated with durable responses to checkpoint immunotherapy and TCR-based cell therapies. She developed high-throughput sequencing methods to track TIL clonotype expansion and persistence. Her work has provided fundamental insights into how TCR diversity impacts antitumor immunity and therapeutic outcomes.